Conférence

BRIO support to scientists

Réalisation : 7 novembre 2014 Mise en ligne : 7 novembre 2014
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
  • audio 1 audio 2 audio 3
Descriptif

BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research community. In this section, BRIO highlights the core support the team can bring to scientists. First, in an era of decreasing and competitive public funds, we look into other funding sources, such as European funds where BRIO and the University can assist in finding and applying to the right call for proposals. Considering the current trends of pharma R&D externalisation, a favorable environment exists to partner with the industry to develop new drugs or fund fundamental research related to marketed drugs or under development. BRIO can assist scientists with the industry interactions to build win-win partnerships. Finally, there are more than 300 scientists interested in cancer research in Bordeaux, all coming from various research disciplines but with limited interactions or knowledge of their peers. BRIO aims at providing solutions to facilitate interactions between scientists, develop new partnerships, improve translational research and build a strong and visible cancer research community.

Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation)
Conditions d'utilisation
Creative Commons (BY NC)
Citer cette ressource:
Univ Bordeaux. (2014, 7 novembre). BRIO support to scientists. [Vidéo]. Canal-U. https://www.canal-u.tv/75313. (Consultée le 27 janvier 2022)
Contacter

Dans la même collection

  • Multisarc
    Conférence
    00:13:08
    Multisarc
    Italiano
    Antoine

    Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by

  • Translational cancer genomics and proteomics
    Conférence
    00:29:16
    Translational cancer genomics and proteomics
    Sleijfer
    Stefan

    Translational science : how to move from biology to clinical applications Evaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as “liquid biopsy” to define and establish

  • Curing leukemia ?
    Conférence
    00:19:52
    Curing leukemia ?
    Mahon
    François-Xavier

    Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

  • Cost-effectiveness analysis for decision making, illustrated theory
    Conférence
    00:19:20
    Cost-effectiveness analysis for decision making, illustrated theory
    Bénard
    Antoine

    Interface technology/clinical/SHS/public health : case study interventional radiology In a health care system with limited resources, each euro invested in a health care intervention is no longer

  • Expert panel discussions : why translational research matters
    Conférence
    01:00:29
    Expert panel discussions : why translational research matters

    En point d'orgue du Scientific BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur  à l'Université d'Edimbourg, anime un débat sur la question de la recherche dite translationnelle,

Avec les mêmes intervenants

  • Bordeaux Cancer Initiative
    Conférence
    00:16:54
    Bordeaux Cancer Initiative
    Dessis
    Damien
    Elustondo
    Frédéric

    Translational science : how to move from biology to clinical applications Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis

Sur le même thème